Latest Insider Transactions at Silk Road Medical Inc (SILK)
This section provides a real-time view of insider transactions for Silk Road Medical Inc (SILK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silk Road Medical Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silk Road Medical Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2024
|
Donald Zurbay |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,610
-100.0%
|
-
|
|
Sep 17
2024
|
Elizabeth H Weatherman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
155,004
-100.0%
|
-
|
|
Sep 17
2024
|
Jack W Lasersohn |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,735
-100.0%
|
-
|
|
Sep 17
2024
|
Tony M. Chou |
SELL
Sale (or disposition) back to the issuer
|
Direct |
85,251
-100.0%
|
-
|
|
Sep 17
2024
|
Tanisha Carino |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,396
-100.0%
|
-
|
|
Sep 17
2024
|
Kevin J. Ballinger |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,666
-100.0%
|
-
|
|
Sep 17
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
70
-100.0%
|
-
|
|
Sep 17
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Sale (or disposition) back to the issuer
|
Direct |
231,961
-100.0%
|
-
|
|
Sep 17
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+50.0%
|
-
|
|
Sep 17
2024
|
Rick D Anderson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,966
-100.0%
|
-
|
|
Sep 17
2024
|
Marie L. Jones VP, Finance and CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,266
-100.0%
|
-
|
|
Sep 17
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
191,988
-100.0%
|
-
|
|
Sep 17
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
29,062
+50.0%
|
-
|
|
Sep 17
2024
|
Andrew S. Davis Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
332,295
-100.0%
|
-
|
|
Sep 17
2024
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,218
+50.0%
|
-
|
|
Sep 17
2024
|
Lucas W. Buchanan COO & CFO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
13,518
-100.0%
|
-
|
|
Sep 17
2024
|
Lucas W. Buchanan COO & CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
554,171
-100.0%
|
-
|
|
Sep 17
2024
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
50,876
+50.0%
|
-
|
|
Sep 17
2024
|
Chas Mc Khann Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,021,438
-100.0%
|
-
|
|
Sep 17
2024
|
Chas Mc Khann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,299,042
+50.0%
|
-
|
|
Aug 19
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
SELL
Open market or private sale
|
Direct |
2,268
-1.37%
|
$61,236
$27.1 P/Share
|
|
Jul 03
2024
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
66
-0.02%
|
$1,782
$27.0 P/Share
|
|
Jun 18
2024
|
Rick D Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+32.87%
|
-
|
|
Jun 18
2024
|
Donald Zurbay |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+31.72%
|
-
|
|
Jun 18
2024
|
Tony M. Chou |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+6.43%
|
-
|
|
Jun 18
2024
|
Jack W Lasersohn |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+25.93%
|
-
|
|
Jun 18
2024
|
Elizabeth H Weatherman |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+3.64%
|
-
|
|
Jun 18
2024
|
Kevin J. Ballinger |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+19.84%
|
-
|
|
Jun 18
2024
|
Tanisha Carino |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+33.96%
|
-
|
|
May 20
2024
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+0.69%
|
$14,000
$7.05 P/Share
|
|
Mar 05
2024
|
Kevin J. Ballinger |
BUY
Open market or private purchase
|
Direct |
11,700
+39.65%
|
$187,200
$16.99 P/Share
|
|
Mar 05
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
3,800
-1.81%
|
$64,600
$17.17 P/Share
|
|
Mar 05
2024
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
9,877
-1.93%
|
$167,909
$17.17 P/Share
|
|
Mar 05
2024
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,481
-1.87%
|
$93,177
$17.17 P/Share
|
|
Mar 05
2024
|
Marie L. Jones VP, Finance and CAO |
SELL
Open market or private sale
|
Direct |
2,602
-3.27%
|
$44,234
$17.17 P/Share
|
|
Mar 05
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
SELL
Open market or private sale
|
Direct |
2,497
-1.49%
|
$42,449
$17.17 P/Share
|
|
Mar 01
2024
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
74,954
+12.8%
|
-
|
|
Mar 01
2024
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,201
+17.5%
|
-
|
|
Mar 01
2024
|
Marie L. Jones VP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
24,555
+23.6%
|
-
|
|
Mar 01
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
42,818
+20.34%
|
-
|
|
Mar 01
2024
|
Chas Mc Khann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,313
+13.25%
|
-
|
|
Mar 01
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
38,674
+15.58%
|
-
|
|
Feb 29
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
3,000
-1.73%
|
$66,000
$22.25 P/Share
|
|
Nov 02
2023
|
Chas Mc Khann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
612,083
+50.0%
|
-
|
|
Oct 27
2023
|
Marie L. Jones VP, Finance and CAO |
SELL
Open market or private sale
|
Direct |
656
-1.18%
|
$3,936
$6.61 P/Share
|
|
Oct 04
2023
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
2,662
-0.61%
|
$39,930
$15.22 P/Share
|
|
Sep 15
2023
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
28,354
+14.02%
|
-
|
|
Sep 15
2023
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
86,076
+40.8%
|
-
|
|
Sep 15
2023
|
Marie L. Jones VP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
7,595
+12.02%
|
-
|
|
Sep 15
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
222,785
+22.62%
|
-
|